TARGETED THERAPY OF FN14-POSITIVE BREAST TUMORS USING A TWEAK-CYTOTOXIN FUSION PROTEIN OR NONCOVALENT COMPLEX

$112,499FY2009Department of the ArmyDOD

University Of Maryland, Baltimore

Investigators